nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A3—Irinotecan—pancreatic cancer	0.107	0.149	CbGbCtD
Clonidine—CYP1A1—Dacarbazine—pancreatic cancer	0.0707	0.0986	CbGbCtD
Clonidine—CYP1A1—Tamoxifen—pancreatic cancer	0.0563	0.0785	CbGbCtD
Clonidine—CYP1A1—Erlotinib—pancreatic cancer	0.0478	0.0667	CbGbCtD
Clonidine—CYP3A5—Tamoxifen—pancreatic cancer	0.0338	0.0471	CbGbCtD
Clonidine—CYP1A2—Dacarbazine—pancreatic cancer	0.0316	0.0441	CbGbCtD
Clonidine—CYP3A5—Erlotinib—pancreatic cancer	0.0287	0.04	CbGbCtD
Clonidine—CYP3A5—Irinotecan—pancreatic cancer	0.0259	0.0362	CbGbCtD
Clonidine—CYP1A2—Tamoxifen—pancreatic cancer	0.0251	0.0351	CbGbCtD
Clonidine—ABCB1—Tamoxifen—pancreatic cancer	0.022	0.0307	CbGbCtD
Clonidine—CYP1A2—Erlotinib—pancreatic cancer	0.0214	0.0298	CbGbCtD
Clonidine—CYP2D6—Tamoxifen—pancreatic cancer	0.0207	0.0289	CbGbCtD
Clonidine—CYP3A5—Docetaxel—pancreatic cancer	0.019	0.0265	CbGbCtD
Clonidine—ABCB1—Gemcitabine—pancreatic cancer	0.0189	0.0264	CbGbCtD
Clonidine—CYP3A5—Sunitinib—pancreatic cancer	0.0189	0.0264	CbGbCtD
Clonidine—ABCB1—Erlotinib—pancreatic cancer	0.0187	0.0261	CbGbCtD
Clonidine—CYP1A2—Fluorouracil—pancreatic cancer	0.0185	0.0258	CbGbCtD
Clonidine—CYP2D6—Erlotinib—pancreatic cancer	0.0176	0.0246	CbGbCtD
Clonidine—ABCB1—Irinotecan—pancreatic cancer	0.0169	0.0235	CbGbCtD
Clonidine—CYP3A4—Tamoxifen—pancreatic cancer	0.0132	0.0184	CbGbCtD
Clonidine—ABCB1—Docetaxel—pancreatic cancer	0.0124	0.0172	CbGbCtD
Clonidine—ABCB1—Sunitinib—pancreatic cancer	0.0123	0.0172	CbGbCtD
Clonidine—CYP3A4—Erlotinib—pancreatic cancer	0.0112	0.0156	CbGbCtD
Clonidine—CYP3A4—Irinotecan—pancreatic cancer	0.0101	0.0141	CbGbCtD
Clonidine—ABCB1—Doxorubicin—pancreatic cancer	0.00922	0.0129	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—pancreatic cancer	0.00869	0.0121	CbGbCtD
Clonidine—CYP3A4—Docetaxel—pancreatic cancer	0.00741	0.0103	CbGbCtD
Clonidine—CYP3A4—Sunitinib—pancreatic cancer	0.00738	0.0103	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—pancreatic cancer	0.00552	0.0077	CbGbCtD
Clonidine—NISCH—Paclitaxel—Docetaxel—pancreatic cancer	0.00475	1	CbGdCrCtD
Clonidine—Diclofenac—CXCL8—pancreatic cancer	0.00115	0.774	CrCbGaD
Clonidine—Diclofenac—PTGS2—pancreatic cancer	0.000334	0.226	CrCbGaD
Clonidine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000226	0.00114	CcSEcCtD
Clonidine—Nausea—Tamoxifen—pancreatic cancer	0.000225	0.00113	CcSEcCtD
Clonidine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000224	0.00113	CcSEcCtD
Clonidine—Fatigue—Gemcitabine—pancreatic cancer	0.000224	0.00113	CcSEcCtD
Clonidine—Pain—Gemcitabine—pancreatic cancer	0.000222	0.00112	CcSEcCtD
Clonidine—Constipation—Gemcitabine—pancreatic cancer	0.000222	0.00112	CcSEcCtD
Clonidine—Nausea—Erlotinib—pancreatic cancer	0.000222	0.00112	CcSEcCtD
Clonidine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000222	0.00112	CcSEcCtD
Clonidine—Diarrhoea—Sunitinib—pancreatic cancer	0.000222	0.00112	CcSEcCtD
Clonidine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000221	0.00111	CcSEcCtD
Clonidine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00022	0.00111	CcSEcCtD
Clonidine—Asthma—Epirubicin—pancreatic cancer	0.000219	0.0011	CcSEcCtD
Clonidine—Pain—Fluorouracil—pancreatic cancer	0.000219	0.0011	CcSEcCtD
Clonidine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000218	0.0011	CcSEcCtD
Clonidine—Muscle spasms—Docetaxel—pancreatic cancer	0.000217	0.00109	CcSEcCtD
Clonidine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000216	0.00109	CcSEcCtD
Clonidine—Dizziness—Sunitinib—pancreatic cancer	0.000214	0.00108	CcSEcCtD
Clonidine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000214	0.00108	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000214	0.00108	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000214	0.00108	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—pancreatic cancer	0.000212	0.00107	CcSEcCtD
Clonidine—Abdominal pain—Irinotecan—pancreatic cancer	0.000211	0.00106	CcSEcCtD
Clonidine—Body temperature increased—Irinotecan—pancreatic cancer	0.000211	0.00106	CcSEcCtD
Clonidine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000211	0.00106	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000209	0.00105	CcSEcCtD
Clonidine—Vomiting—Sunitinib—pancreatic cancer	0.000206	0.00104	CcSEcCtD
Clonidine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000205	0.00103	CcSEcCtD
Clonidine—Dysuria—Epirubicin—pancreatic cancer	0.000205	0.00103	CcSEcCtD
Clonidine—Rash—Sunitinib—pancreatic cancer	0.000204	0.00103	CcSEcCtD
Clonidine—Dermatitis—Sunitinib—pancreatic cancer	0.000204	0.00103	CcSEcCtD
Clonidine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000203	0.00102	CcSEcCtD
Clonidine—Urticaria—Fluorouracil—pancreatic cancer	0.000203	0.00102	CcSEcCtD
Clonidine—Headache—Sunitinib—pancreatic cancer	0.000203	0.00102	CcSEcCtD
Clonidine—Syncope—Docetaxel—pancreatic cancer	0.000203	0.00102	CcSEcCtD
Clonidine—Asthma—Doxorubicin—pancreatic cancer	0.000202	0.00102	CcSEcCtD
Clonidine—Pollakiuria—Epirubicin—pancreatic cancer	0.000202	0.00102	CcSEcCtD
Clonidine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000202	0.00102	CcSEcCtD
Clonidine—Palpitations—Docetaxel—pancreatic cancer	0.0002	0.00101	CcSEcCtD
Clonidine—Weight increased—Epirubicin—pancreatic cancer	0.000199	0.001	CcSEcCtD
Clonidine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000199	0.001	CcSEcCtD
Clonidine—Cough—Docetaxel—pancreatic cancer	0.000197	0.000993	CcSEcCtD
Clonidine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000197	0.000989	CcSEcCtD
Clonidine—Drowsiness—Epirubicin—pancreatic cancer	0.000195	0.000982	CcSEcCtD
Clonidine—Arthralgia—Docetaxel—pancreatic cancer	0.000192	0.000968	CcSEcCtD
Clonidine—Chest pain—Docetaxel—pancreatic cancer	0.000192	0.000968	CcSEcCtD
Clonidine—Nausea—Sunitinib—pancreatic cancer	0.000192	0.000968	CcSEcCtD
Clonidine—Asthenia—Irinotecan—pancreatic cancer	0.000191	0.000963	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000191	0.000962	CcSEcCtD
Clonidine—Urinary tract infection—Epirubicin—pancreatic cancer	0.00019	0.000954	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—pancreatic cancer	0.000189	0.000953	CcSEcCtD
Clonidine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000188	0.000948	CcSEcCtD
Clonidine—Dry mouth—Docetaxel—pancreatic cancer	0.000188	0.000947	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000188	0.000947	CcSEcCtD
Clonidine—Sweating—Epirubicin—pancreatic cancer	0.000187	0.000941	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000187	0.000941	CcSEcCtD
Clonidine—Asthenia—Gemcitabine—pancreatic cancer	0.000186	0.000939	CcSEcCtD
Clonidine—Confusional state—Docetaxel—pancreatic cancer	0.000186	0.000936	CcSEcCtD
Clonidine—Oedema—Docetaxel—pancreatic cancer	0.000184	0.000928	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—pancreatic cancer	0.000184	0.000927	CcSEcCtD
Clonidine—Epistaxis—Epirubicin—pancreatic cancer	0.000184	0.000926	CcSEcCtD
Clonidine—Pruritus—Gemcitabine—pancreatic cancer	0.000184	0.000925	CcSEcCtD
Clonidine—Infection—Docetaxel—pancreatic cancer	0.000183	0.000922	CcSEcCtD
Clonidine—Diarrhoea—Irinotecan—pancreatic cancer	0.000183	0.000919	CcSEcCtD
Clonidine—Shock—Docetaxel—pancreatic cancer	0.000181	0.000913	CcSEcCtD
Clonidine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000181	0.00091	CcSEcCtD
Clonidine—Pruritus—Fluorouracil—pancreatic cancer	0.000181	0.00091	CcSEcCtD
Clonidine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000181	0.000909	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—pancreatic cancer	0.00018	0.000908	CcSEcCtD
Clonidine—Tachycardia—Docetaxel—pancreatic cancer	0.00018	0.000906	CcSEcCtD
Clonidine—Skin disorder—Docetaxel—pancreatic cancer	0.000179	0.000902	CcSEcCtD
Clonidine—Bradycardia—Epirubicin—pancreatic cancer	0.000178	0.000897	CcSEcCtD
Clonidine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000178	0.000895	CcSEcCtD
Clonidine—Dizziness—Irinotecan—pancreatic cancer	0.000176	0.000888	CcSEcCtD
Clonidine—Anorexia—Docetaxel—pancreatic cancer	0.000176	0.000885	CcSEcCtD
Clonidine—Rhinitis—Epirubicin—pancreatic cancer	0.000176	0.000884	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000175	0.000883	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—pancreatic cancer	0.000175	0.000881	CcSEcCtD
Clonidine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000175	0.00088	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000174	0.000877	CcSEcCtD
Clonidine—Sweating—Doxorubicin—pancreatic cancer	0.000173	0.000871	CcSEcCtD
Clonidine—Hypotension—Docetaxel—pancreatic cancer	0.000172	0.000867	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—pancreatic cancer	0.00017	0.000857	CcSEcCtD
Clonidine—Vomiting—Irinotecan—pancreatic cancer	0.00017	0.000854	CcSEcCtD
Clonidine—Dizziness—Fluorouracil—pancreatic cancer	0.000169	0.000851	CcSEcCtD
Clonidine—Rash—Irinotecan—pancreatic cancer	0.000168	0.000847	CcSEcCtD
Clonidine—Dermatitis—Irinotecan—pancreatic cancer	0.000168	0.000846	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000168	0.000846	CcSEcCtD
Clonidine—Headache—Irinotecan—pancreatic cancer	0.000167	0.000841	CcSEcCtD
Clonidine—Insomnia—Docetaxel—pancreatic cancer	0.000167	0.00084	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—pancreatic cancer	0.000166	0.000834	CcSEcCtD
Clonidine—Vomiting—Gemcitabine—pancreatic cancer	0.000165	0.000832	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—pancreatic cancer	0.000165	0.00083	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—pancreatic cancer	0.000164	0.000828	CcSEcCtD
Clonidine—Somnolence—Docetaxel—pancreatic cancer	0.000164	0.000825	CcSEcCtD
Clonidine—Rash—Gemcitabine—pancreatic cancer	0.000164	0.000825	CcSEcCtD
Clonidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000164	0.000824	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—pancreatic cancer	0.000164	0.000824	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—pancreatic cancer	0.000163	0.000822	CcSEcCtD
Clonidine—Headache—Gemcitabine—pancreatic cancer	0.000163	0.000819	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000163	0.000818	CcSEcCtD
Clonidine—Vomiting—Fluorouracil—pancreatic cancer	0.000162	0.000818	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—pancreatic cancer	0.000162	0.000818	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—pancreatic cancer	0.000162	0.000815	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000161	0.000811	CcSEcCtD
Clonidine—Rash—Fluorouracil—pancreatic cancer	0.000161	0.000811	CcSEcCtD
Clonidine—Dermatitis—Fluorouracil—pancreatic cancer	0.000161	0.00081	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—pancreatic cancer	0.00016	0.000807	CcSEcCtD
Clonidine—Headache—Fluorouracil—pancreatic cancer	0.00016	0.000806	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000159	0.000801	CcSEcCtD
Clonidine—Fatigue—Docetaxel—pancreatic cancer	0.000159	0.0008	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—pancreatic cancer	0.000159	0.0008	CcSEcCtD
Clonidine—Nausea—Irinotecan—pancreatic cancer	0.000158	0.000798	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000158	0.000794	CcSEcCtD
Clonidine—Pain—Docetaxel—pancreatic cancer	0.000158	0.000794	CcSEcCtD
Clonidine—Constipation—Docetaxel—pancreatic cancer	0.000158	0.000794	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—pancreatic cancer	0.000156	0.000787	CcSEcCtD
Clonidine—Alopecia—Epirubicin—pancreatic cancer	0.000155	0.000779	CcSEcCtD
Clonidine—Nausea—Gemcitabine—pancreatic cancer	0.000154	0.000777	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—pancreatic cancer	0.000153	0.000772	CcSEcCtD
Clonidine—Erythema—Epirubicin—pancreatic cancer	0.000152	0.000767	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000152	0.000765	CcSEcCtD
Clonidine—Nausea—Fluorouracil—pancreatic cancer	0.000152	0.000764	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—pancreatic cancer	0.000151	0.000762	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—pancreatic cancer	0.000151	0.00076	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000151	0.000759	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00015	0.000757	CcSEcCtD
Clonidine—Tension—Epirubicin—pancreatic cancer	0.00015	0.000753	CcSEcCtD
Clonidine—Nervousness—Epirubicin—pancreatic cancer	0.000148	0.000745	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—pancreatic cancer	0.000147	0.00074	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—pancreatic cancer	0.000147	0.000738	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000146	0.000735	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—pancreatic cancer	0.000146	0.000734	CcSEcCtD
Clonidine—Body temperature increased—Docetaxel—pancreatic cancer	0.000146	0.000734	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000145	0.000728	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—pancreatic cancer	0.000144	0.000723	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—pancreatic cancer	0.000143	0.000721	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—pancreatic cancer	0.000142	0.000714	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000141	0.000712	CcSEcCtD
Clonidine—Erythema—Doxorubicin—pancreatic cancer	0.000141	0.00071	CcSEcCtD
Clonidine—Agitation—Epirubicin—pancreatic cancer	0.00014	0.000705	CcSEcCtD
Clonidine—Tension—Doxorubicin—pancreatic cancer	0.000138	0.000697	CcSEcCtD
Clonidine—Malaise—Epirubicin—pancreatic cancer	0.000137	0.000692	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—pancreatic cancer	0.000137	0.000689	CcSEcCtD
Clonidine—Syncope—Epirubicin—pancreatic cancer	0.000137	0.000688	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000136	0.000684	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000136	0.000682	CcSEcCtD
Clonidine—Palpitations—Epirubicin—pancreatic cancer	0.000135	0.000678	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000134	0.000674	CcSEcCtD
Clonidine—Cough—Epirubicin—pancreatic cancer	0.000133	0.000669	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—pancreatic cancer	0.000133	0.000669	CcSEcCtD
Clonidine—Asthenia—Docetaxel—pancreatic cancer	0.000132	0.000666	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000131	0.000659	CcSEcCtD
Clonidine—Pruritus—Docetaxel—pancreatic cancer	0.000131	0.000657	CcSEcCtD
Clonidine—Chest pain—Epirubicin—pancreatic cancer	0.00013	0.000653	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—pancreatic cancer	0.00013	0.000653	CcSEcCtD
Clonidine—Agitation—Doxorubicin—pancreatic cancer	0.00013	0.000652	CcSEcCtD
Clonidine—Anxiety—Epirubicin—pancreatic cancer	0.000129	0.000651	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000129	0.000649	CcSEcCtD
Clonidine—Discomfort—Epirubicin—pancreatic cancer	0.000128	0.000645	CcSEcCtD
Clonidine—Malaise—Doxorubicin—pancreatic cancer	0.000127	0.00064	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—pancreatic cancer	0.000127	0.000639	CcSEcCtD
Clonidine—Syncope—Doxorubicin—pancreatic cancer	0.000126	0.000637	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—pancreatic cancer	0.000126	0.000635	CcSEcCtD
Clonidine—Confusional state—Epirubicin—pancreatic cancer	0.000125	0.000631	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—pancreatic cancer	0.000125	0.000627	CcSEcCtD
Clonidine—Oedema—Epirubicin—pancreatic cancer	0.000124	0.000626	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000124	0.000624	CcSEcCtD
Clonidine—Infection—Epirubicin—pancreatic cancer	0.000124	0.000622	CcSEcCtD
Clonidine—Cough—Doxorubicin—pancreatic cancer	0.000123	0.000619	CcSEcCtD
Clonidine—Shock—Epirubicin—pancreatic cancer	0.000122	0.000616	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000122	0.000614	CcSEcCtD
Clonidine—Dizziness—Docetaxel—pancreatic cancer	0.000122	0.000614	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000122	0.000613	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—pancreatic cancer	0.000121	0.000611	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—pancreatic cancer	0.000121	0.000608	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00012	0.000605	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—pancreatic cancer	0.00012	0.000604	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—pancreatic cancer	0.00012	0.000604	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—pancreatic cancer	0.00012	0.000602	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000119	0.0006	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—pancreatic cancer	0.000119	0.000597	CcSEcCtD
Clonidine—Anorexia—Epirubicin—pancreatic cancer	0.000119	0.000597	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—pancreatic cancer	0.000117	0.000591	CcSEcCtD
Clonidine—Vomiting—Docetaxel—pancreatic cancer	0.000117	0.00059	CcSEcCtD
Clonidine—Rash—Docetaxel—pancreatic cancer	0.000116	0.000585	CcSEcCtD
Clonidine—Hypotension—Epirubicin—pancreatic cancer	0.000116	0.000585	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—pancreatic cancer	0.000116	0.000585	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—pancreatic cancer	0.000116	0.000584	CcSEcCtD
Clonidine—Headache—Docetaxel—pancreatic cancer	0.000116	0.000582	CcSEcCtD
Clonidine—Oedema—Doxorubicin—pancreatic cancer	0.000115	0.000579	CcSEcCtD
Clonidine—Infection—Doxorubicin—pancreatic cancer	0.000114	0.000576	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000113	0.00057	CcSEcCtD
Clonidine—Shock—Doxorubicin—pancreatic cancer	0.000113	0.00057	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000113	0.000568	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000113	0.000567	CcSEcCtD
Clonidine—Insomnia—Epirubicin—pancreatic cancer	0.000113	0.000566	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—pancreatic cancer	0.000112	0.000565	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—pancreatic cancer	0.000112	0.000563	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—pancreatic cancer	0.000112	0.000562	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000111	0.00056	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—pancreatic cancer	0.000111	0.000558	CcSEcCtD
Clonidine—Somnolence—Epirubicin—pancreatic cancer	0.000111	0.000557	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—pancreatic cancer	0.00011	0.000552	CcSEcCtD
Clonidine—Nausea—Docetaxel—pancreatic cancer	0.00011	0.000551	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—pancreatic cancer	0.000108	0.000544	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—pancreatic cancer	0.000108	0.000541	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000107	0.000541	CcSEcCtD
Clonidine—Fatigue—Epirubicin—pancreatic cancer	0.000107	0.00054	CcSEcCtD
Clonidine—Pain—Epirubicin—pancreatic cancer	0.000106	0.000535	CcSEcCtD
Clonidine—Constipation—Epirubicin—pancreatic cancer	0.000106	0.000535	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000105	0.000528	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—pancreatic cancer	0.000104	0.000524	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000103	0.00052	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000103	0.000517	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000103	0.000516	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—pancreatic cancer	0.000102	0.000515	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000102	0.000512	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—pancreatic cancer	0.0001	0.000504	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.94e-05	0.0005	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—pancreatic cancer	9.92e-05	0.000499	CcSEcCtD
Clonidine—Urticaria—Epirubicin—pancreatic cancer	9.88e-05	0.000497	CcSEcCtD
Clonidine—Constipation—Doxorubicin—pancreatic cancer	9.84e-05	0.000495	CcSEcCtD
Clonidine—Pain—Doxorubicin—pancreatic cancer	9.84e-05	0.000495	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—pancreatic cancer	9.84e-05	0.000495	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—pancreatic cancer	9.84e-05	0.000495	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—pancreatic cancer	9.49e-05	0.000477	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.41e-05	0.000474	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—pancreatic cancer	9.17e-05	0.000461	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—pancreatic cancer	9.15e-05	0.00046	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—pancreatic cancer	9.1e-05	0.000458	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—pancreatic cancer	9.1e-05	0.000458	CcSEcCtD
Clonidine—Asthenia—Epirubicin—pancreatic cancer	8.93e-05	0.000449	CcSEcCtD
Clonidine—Pruritus—Epirubicin—pancreatic cancer	8.8e-05	0.000443	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—pancreatic cancer	8.51e-05	0.000428	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—pancreatic cancer	8.48e-05	0.000427	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—pancreatic cancer	8.26e-05	0.000416	CcSEcCtD
Clonidine—Dizziness—Epirubicin—pancreatic cancer	8.23e-05	0.000414	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—pancreatic cancer	8.14e-05	0.00041	CcSEcCtD
Clonidine—Vomiting—Epirubicin—pancreatic cancer	7.91e-05	0.000398	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—pancreatic cancer	7.88e-05	0.000396	CcSEcCtD
Clonidine—Rash—Epirubicin—pancreatic cancer	7.84e-05	0.000395	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—pancreatic cancer	7.84e-05	0.000394	CcSEcCtD
Clonidine—Headache—Epirubicin—pancreatic cancer	7.79e-05	0.000392	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—pancreatic cancer	7.61e-05	0.000383	CcSEcCtD
Clonidine—Nausea—Epirubicin—pancreatic cancer	7.39e-05	0.000372	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—pancreatic cancer	7.32e-05	0.000368	CcSEcCtD
Clonidine—Rash—Doxorubicin—pancreatic cancer	7.26e-05	0.000365	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—pancreatic cancer	7.25e-05	0.000365	CcSEcCtD
Clonidine—Headache—Doxorubicin—pancreatic cancer	7.21e-05	0.000363	CcSEcCtD
Clonidine—Nausea—Doxorubicin—pancreatic cancer	6.84e-05	0.000344	CcSEcCtD
Clonidine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	8.13e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	8.1e-06	0.000104	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	8.1e-06	0.000104	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—TYMS—pancreatic cancer	8.09e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	8.09e-06	0.000104	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.08e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	8.06e-06	0.000103	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	8.04e-06	0.000103	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—pancreatic cancer	8.03e-06	0.000103	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GCG—pancreatic cancer	7.99e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	7.98e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	7.96e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	7.93e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	7.91e-06	0.000101	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	7.87e-06	0.000101	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.8e-06	0.0001	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	7.8e-06	0.0001	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	7.77e-06	9.97e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	7.77e-06	9.96e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	7.73e-06	9.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	7.73e-06	9.91e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	7.72e-06	9.9e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.7e-06	9.87e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	7.69e-06	9.86e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	7.67e-06	9.84e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	7.65e-06	9.81e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	7.64e-06	9.8e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—TYMS—pancreatic cancer	7.63e-06	9.78e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	7.61e-06	9.76e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—pancreatic cancer	7.6e-06	9.74e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.58e-06	9.72e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	7.55e-06	9.68e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—STK11—pancreatic cancer	7.51e-06	9.63e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	7.49e-06	9.6e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	7.49e-06	9.6e-05	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	7.46e-06	9.56e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	7.44e-06	9.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	7.42e-06	9.51e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	7.39e-06	9.47e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	7.35e-06	9.42e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	7.25e-06	9.3e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	7.19e-06	9.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	7.18e-06	9.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	7.18e-06	9.21e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—pancreatic cancer	7.18e-06	9.2e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	7.12e-06	9.13e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	7.1e-06	9.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.05e-06	9.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	7.04e-06	9.03e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTEN—pancreatic cancer	7e-06	8.98e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	6.99e-06	8.96e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	6.98e-06	8.95e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	6.97e-06	8.94e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	6.94e-06	8.9e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	6.93e-06	8.88e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	6.92e-06	8.87e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	6.88e-06	8.82e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	6.8e-06	8.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	6.78e-06	8.69e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	6.77e-06	8.68e-05	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	6.73e-06	8.63e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.73e-06	8.63e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—pancreatic cancer	6.71e-06	8.6e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	6.67e-06	8.55e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	6.67e-06	8.55e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	6.65e-06	8.53e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—pancreatic cancer	6.62e-06	8.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	6.58e-06	8.44e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOE—pancreatic cancer	6.58e-06	8.44e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	6.54e-06	8.39e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	6.54e-06	8.38e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	6.52e-06	8.36e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	6.51e-06	8.35e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	6.49e-06	8.33e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	6.47e-06	8.29e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.46e-06	8.28e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	6.44e-06	8.26e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	6.43e-06	8.25e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CD44—pancreatic cancer	6.43e-06	8.24e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	6.41e-06	8.22e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	6.37e-06	8.16e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	6.31e-06	8.1e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	6.31e-06	8.08e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	6.29e-06	8.06e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	6.27e-06	8.04e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	6.27e-06	8.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.25e-06	8.02e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	6.23e-06	7.99e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	6.21e-06	7.96e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOE—pancreatic cancer	6.2e-06	7.95e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	6.19e-06	7.94e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	6.19e-06	7.94e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	6.18e-06	7.93e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GCG—pancreatic cancer	6.17e-06	7.9e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	6.13e-06	7.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	6.12e-06	7.84e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.11e-06	7.84e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	6.07e-06	7.78e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	6.03e-06	7.73e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	6.01e-06	7.7e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	5.98e-06	7.66e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	5.97e-06	7.65e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	5.94e-06	7.62e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	5.92e-06	7.59e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	5.91e-06	7.58e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	5.89e-06	7.55e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	5.86e-06	7.51e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	5.81e-06	7.45e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	5.8e-06	7.43e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—STK11—pancreatic cancer	5.8e-06	7.43e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	5.77e-06	7.4e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	5.76e-06	7.39e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	5.76e-06	7.38e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—pancreatic cancer	5.73e-06	7.35e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	5.71e-06	7.32e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	5.7e-06	7.31e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	5.69e-06	7.3e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—pancreatic cancer	5.69e-06	7.29e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	5.68e-06	7.28e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	5.66e-06	7.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	5.66e-06	7.25e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—pancreatic cancer	5.65e-06	7.24e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	5.64e-06	7.24e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	5.62e-06	7.21e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	5.61e-06	7.19e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.6e-06	7.18e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	5.59e-06	7.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	5.5e-06	7.06e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	5.5e-06	7.05e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	5.45e-06	6.99e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	5.43e-06	6.96e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.4e-06	6.93e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	5.34e-06	6.85e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	5.33e-06	6.84e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	5.3e-06	6.8e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	5.29e-06	6.78e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	5.29e-06	6.78e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	5.25e-06	6.74e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOE—pancreatic cancer	5.25e-06	6.74e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	5.25e-06	6.73e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	5.24e-06	6.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	5.22e-06	6.7e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.22e-06	6.69e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.21e-06	6.68e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	5.21e-06	6.68e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	5.21e-06	6.67e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	5.2e-06	6.66e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	5.15e-06	6.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	5.15e-06	6.6e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	5.14e-06	6.59e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	5.12e-06	6.56e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	5.11e-06	6.55e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	5.1e-06	6.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	5.06e-06	6.49e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	4.99e-06	6.4e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.99e-06	6.39e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.97e-06	6.38e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	4.94e-06	6.33e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	4.93e-06	6.32e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—pancreatic cancer	4.92e-06	6.31e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.92e-06	6.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	4.9e-06	6.28e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	4.88e-06	6.26e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	4.87e-06	6.24e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	4.85e-06	6.22e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	4.81e-06	6.17e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	4.79e-06	6.14e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	4.78e-06	6.13e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	4.78e-06	6.12e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	4.76e-06	6.1e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	4.76e-06	6.1e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	4.75e-06	6.09e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.74e-06	6.08e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	4.74e-06	6.08e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	4.73e-06	6.07e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	4.68e-06	6.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	4.64e-06	5.95e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	4.62e-06	5.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	4.58e-06	5.87e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.58e-06	5.87e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	4.57e-06	5.85e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.55e-06	5.84e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	4.53e-06	5.81e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.51e-06	5.78e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	4.5e-06	5.76e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	4.43e-06	5.67e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	4.42e-06	5.67e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	4.41e-06	5.65e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	4.3e-06	5.51e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.29e-06	5.5e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	4.28e-06	5.48e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	4.25e-06	5.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	4.25e-06	5.45e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.25e-06	5.45e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	4.24e-06	5.44e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	4.24e-06	5.44e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.17e-06	5.34e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	4.16e-06	5.33e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.13e-06	5.3e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	4.09e-06	5.25e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	4.07e-06	5.21e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOE—pancreatic cancer	4.06e-06	5.2e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—pancreatic cancer	4.04e-06	5.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	4.01e-06	5.14e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	4e-06	5.13e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	4e-06	5.12e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	3.95e-06	5.07e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	3.94e-06	5.05e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—pancreatic cancer	3.93e-06	5.04e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	3.93e-06	5.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	3.93e-06	5.04e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—pancreatic cancer	3.87e-06	4.96e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	3.87e-06	4.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	3.82e-06	4.9e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	3.76e-06	4.82e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.71e-06	4.75e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.68e-06	4.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.66e-06	4.69e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	3.65e-06	4.68e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.63e-06	4.66e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	3.61e-06	4.63e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.61e-06	4.63e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.6e-06	4.62e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.53e-06	4.53e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	3.49e-06	4.48e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	3.47e-06	4.45e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	3.37e-06	4.33e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.36e-06	4.3e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	3.34e-06	4.28e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	3.32e-06	4.26e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—pancreatic cancer	3.28e-06	4.2e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	3.25e-06	4.16e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.22e-06	4.12e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.14e-06	4.03e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.1e-06	3.98e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—pancreatic cancer	3e-06	3.85e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	2.95e-06	3.78e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—pancreatic cancer	2.84e-06	3.64e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.8e-06	3.6e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.78e-06	3.56e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.77e-06	3.56e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	2.74e-06	3.51e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.61e-06	3.35e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.42e-06	3.11e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—pancreatic cancer	2.27e-06	2.91e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.22e-06	2.84e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.14e-06	2.74e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.81e-06	2.32e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.71e-06	2.19e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.4e-06	1.79e-05	CbGpPWpGaD
